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Abstract Prolonged in vitro culture of human embryonic
stem (hES) cells can result in chromosomal abnormalities
believed to confer a selective advantage. This potential
occurrence has crucial implications for the appropriate use
of hES cells for research and therapeutic purposes. In view
of this, time-point karyotypic evaluation to assess genetic
stability is recommended as a necessary control test to be
carried out during extensive ‘passaging’. Standard techni-
ques currently used for the cytogenetic assessment of ES
cells include G-banding and/or Fluorescence in situ
Hybridization (FISH)-based protocols for karyotype analy-
sis, including M-FISH and SKY. Critical for both banding
and FISH techniques are the number and quality of
metaphase spreads available for analysis at the microscope.
Protocols for chromosome preparation from hES and
human induced pluripotent stem (hiPS) cells published so
far appear to differ considerably from one laboratory to
another. Here we present an optimized technique, in which
both the number and the quality of chromosome metaphase
spreads were substantially improved when compared to
current standard techniques for chromosome preparations.
We believe our protocol represents a significant advance-
ment in this line of work, and has the required attributes of
simplicity and consistency to be widely accepted as a
reference method for high quality, fast chromosomal
analysis of human ES and iPS cells.
Keywords Human embryonic stem cells.Induced
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Introduction
A euploid karyotype is one of the defining characteristics of
hES cells [1]. Once established, hES cell lines are expected
to be chromosomally stable. However, karyotypic abnor-
malities of hES cells in long term cultures have been
repeatedly reported by independent laboratories [2]. Some
of the recurring abnormalities, for instance trisomy 12 and
trisomy 17, appear to provide a selective advantage, with
cells carrying such chromosomal extra copies being able to
replace the cell population in 5–10 passages [3]. The
duration of culture, conditions (presence or absence of
feeders) and replace-by-passaging methods (mechanical
versus enzymatic) have been pointed at as possible
contributing factors to chromosomal changes in hES cells
[4, 5]. However, recent evidence seems to support the
notion that regardless of culture conditions, some hES cell
lines are inherently more inclined to karyotypic instability
[6]. To which extent differences in the chromosomal
complement affect their ability to differentiate, as well as
their proliferative capacity, is still being investigated [7, 8].
In the meantime, while establishing and/or maintaining hES
cell lines, time-point karyotypic analysis is widely recom-
mended as one of the important steps in the quality control
process [3, 9–11]. There have been a few reports under-
scoring an increasing interest in the possible use of
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Genomic Hybridization (CGH), single nucleotide polymor-
phism (SNP) analysis and transcriptional profiling—to
monitor the chromosomal stability of hES and hiPS cells
in culture [12–14]. However, classical and molecular
cytogenetic protocols are still considered the default
approach for routine karyotypic assessment. The analysis
at the microscope that classical cytogenetic protocols—
such as G-banding—entail is extremely laborious and
requires highly specialized training. More modern and
user-friendly Fluorescence in situ Hybridization (FISH)-
based protocols for karyotyping, such as Multiplex FISH
(M-FISH) and Spectral Karyotyping (SKY), or simple
“target analysis” protocols to detect recurring aneuplodies
by means of chromosome specific probes, provide a
suitable alternative, and are increasingly used by different
laboratories for in-house, rapid chromosomal assessment of
ES cells. Crucial for both banding and FISH techniques are
the number and quality of metaphase ‘spreads’ available for
analysis at the microscope. Protocols for chromosome
preparation (or ‘harvesting’) from hES cells published so
far appear to vary considerably from one laboratory to
another. In this paper we describe an optimized technique
for chromosome preparation from hES and hiPS cells, in
which both the number and the quality of metaphase




1. hES cells or iPS cells
2. 1×Phosphate Buffered Saline (PBS)
3. Matrigel (BD, U.K.)
4. mTeSR™1 (STEMCELL Technologies Inc, France)
5. TrypLE Express 1× (Invitrogen, U.K.)
6. ROCK inhibitor Y-27632 (Merck Biosciences, Germany)
7. Penicillin at 10,000 units ml
−1 and Streptomycin at
10 mg ml
−1
8. 6-well culture dish(es)
9. 15 ml conical centrifuge tubes
10. Access to a hemocytometer
11. Access to a Class II microbiological cabinet
12. Access to an incubator at 37°C with 5% CO2
13. Access to an inverted microscope
14. Access to a bench-top centrifuge
Chromosome Harvest
1. Nocodazole (Sigma Aldrich, U.K., http://www.
sigmaaldrich.com), 2.5 mg/ml stock solution in
dimethyl sulfoxide, (DMSO) (Sigma Aldrich, U.K)
(Note 1). Aliquot and store at −20°C
2. “Buffered” hypotonic solution (0.4% KCl with HEPES)
(Genial Genetics, U.K., http://www.genialgenetics.com)
3. Carnoy’s fixative solution: 3:1 (v/v) methanol/glacial
acetic acid, freshly prepared
4. Pre-cleaned microscope slides (VWR International)
5. 1 mL disposable plastic Pasteur pipettes
6. Slide storage boxes (VWR International)
7. Access to a water-bath at 37°C
8. Access to a phase-contrast microscope with a 10× or
20× objective
Chromosome Quality Assessment
1. Vectashield mounting medium with 4′,6-diamidino-2-
phenylindole (DAPI) (Vector Laboratories, UK)
2. 24XCyte mFISH probe kit (MetaSystems, Germany,
http://www.metasystems-international.com)
3. Access to an epifluorescent light microscope with a
63× and/or a 100× oil immersion objective equipped
with a charge-coupled device (CCD) camera and
appropriate operating software for digital image cap-
turing and analysis (e.g. CytoVysion system), consist-
ing of an Olympus BX-51 epifluorescence microscope




1. Cells are grown in a feeder free system in a 6-well dish
(Note 2).
2. Two days before the chromosome harvest procedure,
remove the spent medium from a well of confluent cells.
3. Add 1 ml of sterile PBS, at 37°C, to wash the cells, and
remove.
4. Add 0.5 ml of sterile TrypLE Express, warmed at 37°C.
Place the dish in a 37°C incubator, for 5 min. Using an
inverted microscope, confirm that all the cells have
detached from the tissue culture dish.
5. Resuspend the cells in 10 ml of warm PBS, at 37°C,
and transfer to a 15 ml conical centrifuge tube.
6. Count the cell number using a hemocytometer cell
counter.
7. Centrifuge the cell suspension at 365 g for 10 min, and
resuspend 1–2×10
6 cells in 2 ml of mTeSR™1m e d i u m .
8. Add ROCK inhibitor Y-27632 to a final concentration
of 10 μM, and plate on a fresh well, coated in Matrigel.
9. Place in the CO2 thermostatic incubator.
472 Stem Cell Rev and Rep (2011) 7:471–477Chromosome Harvest and Quality Assessment
1. The day after, change medium and add nocoda-
zole at a final concentration of 0.1 μg/ml, and
incubate for 16 h in the CO2 thermostatic
incubator (Note 3).
2. Following incubation with the mitotic synchronizing
agent, trypsinize the cells as described above, collect
Fig. 1 Efficiency of mitotic arrest following treatment with either
demecolcine or nocodazole. Different concentrations and incubation
times were compared. After fixation the cells were stained with DAPI,
and analyzed at the microscope. Ten random fields from each of the
slides prepared under different conditions were captured with Genus
on the CytoVision system. The yellow arrows identify metaphasic
cells
Percentage of metaphase cells Total number of cells scored
Demecolcine 0.1 mg/ml, 4 h 1.5% 471
Demecolcine 0.1 μg/ml, 4 h 0.5% 854
Demecolcine 0.1 mg/ml, 16 h 3.2% 279
Demecolcine 0.1 μg/ml, 16 h 8% 249
Nocodazole 0.1 μg/ml, 4 h 2.6% 1,254
Nocodazole 0.1 μg/ml, 16 h 15.2% 788
Table 1 Mitotic arrest efficacy
Stem Cell Rev and Rep (2011) 7:471–477 473in the culture medium, and centrifuge at 365 g, for
10 min.
3. Remove the supernatant by pipetting it out of the tube,
and fully resuspend the cell pellet by gently flicking
the tube.
4. Add 5 ml of “Buffered” hypotonic solution (Notes 4
and 5), and pipette delicately the cell suspension, to
evenly disperse the cells. Incubate for 30 min at 37°C.
5. Centrifuge the cells as before.
6. Gently resuspend the cell pellet, and quickly add
about 500 μl of cold Carnoy’s fixative solution.
7. Mix by pipetting, then bring the total volume up to
10 ml with fresh cold fixative. Incubate for 30 min at
room temperature.
8. Centrifuge the cells as before and wash in fixative for
a second time. Incubate for 10 min.
9. Following a final spin, resuspend the cell pellet in
200–300 μl of fresh fixative, and drop 30–50 μlo ft h e
cell suspensions onto clean slides.
10. Places the slides on a warm plate, 37°C, and allow to
air-dry.
11. Check the cell suspension quality by observing the
slide with a phase contrast microscope, 10× objective.
There should be a good number of metaphases, and no
cytoplasmic halo should be visible (Note 6).
Notes
1. It is important to use a very concentrated nocodazole
stock solution, so that a minimal volume of DMSO is
Table 2 Statistical comparisons of the differences between treatments (2×2 contingency table, analysed with Fisher exact test, 2-tailed)
Demecolcine
0.1 μg/ml, 4 h
Demecolcine
0.1 mg/ml, 16 h
Demecolcine
0.1 μg/ml, 16 h
Nocodazole
0.1 μg/ml, 4 h
Nocodazole
0.1 μg/ml, 16 h
Demecolcine 0.1 mg/ml, 4 h p=0.062 p=0.1265 p<0.0001 p=0.2083 p<0.0001
Demecolcine 0.1 μg/ml, 4 h p=0.0010 p<0.0001 p<0.0001 p<0.0001
Demecolcine 0.1 mg/ml, 16 h p=0.0341 p=0.4163 p<0.0001
Demecolcine 0.1 μg/ml, 16 h p=0.0003 p=0.0098
Nocodazole 0.1 μg/ml, 4 h p<0.0001
Fig. 2 Assessment of chromo-
some overlaps following differ-
ent mitotic and hypotonic
treatments. The number of
chromosome overlaps per meta-
phase was compared in four
different ‘harvest’ conditions.
Where the metaphase quality
was poor, we assigned an arbi-
trary number of 23 overlaps per
metaphase, meaning that all the
chromosomes were involved in
at least one overlapping event
474 Stem Cell Rev and Rep (2011) 7:471–477added to the cell culture, as an excess of DMSO might
be toxic to the hES/hiPS cells. The stock solution may
be diluted in PBS immediately prior to use, but discard
any unused diluted material as nocodazole is not stable
for prolonged periods when diluted in a water-based
buffer.
2. For our study we used two human embryonic stem cell
lines—HUES-2 and HUES-10 [15]—cultured under
license from the UK Stem Cell Steering Committee—
and one human induced pluripotent stem cell line—
iPS-DF19-9-11T.H [16]—grown as in Karlsson et al.
[17]. Briefly, cells were seeded onto wells coated with
Matrigel and cultured in mTeSR™1 medium with the
addition of 10 μM ROCK inhibitor Y-27632. The
protocol for chromosome preparation here presented
works equally well with hES and hiPS cells grown on a
mouse embryonic fibroblasts (MEF) feeder layer.
3. Standard protocols for chromosome preparation in stem
cells normally make use of Colcemid® (a synonym of
demecolcine in solution), a well known and widely
used mitotic spindle inhibitor. Oddly, concentrations of
demecolcine used and published so far by different
research groups appear to vary strikingly, the most
frequently used concentration being either 0.1 μg/ml or
0.1 mg/ml. Accordingly, we set up parallel cultures of
HUES-2 cells testing two different concentrations of
demecolcine (0.1 μg/ml and 0.1 mg/ml), and compared
them to HUES-2 cell cultures treated with nocodazole,
an alternative anti-mitotic agent, at the final concentra-
tion of 0.1 μg/ml. The cultures were incubated with the
mitotic agents for either 4 h or 16 h (effectively an
overnight incubation). After fixation, the cells were
stained with 4′,6-diamidino-2-phenylindole (DAPI),
and analyzed at the microscope (Fig. 1). Ten random
fields from each of the slides prepared under different
conditions were collected. The efficacy of the mitotic
arrest treatment was assessed dividing the total number
of metaphases observed by the total number of cells
analyzed (Tables 1 and 2). The statistical significance
of the differences between the various treatments was
measured using a 2×2 contingency table, with Fisher
exact test. Comparison between the cultures revealed a
sustained incubation (16 h) with a low dose of
nocodazole (0.1 μg/ml) as the optimal mitotic arrest
treatment able to provide the highest yield of meta-
phases (15.2%). A sustained incubation (16 h) with a
low dose of demecolcine (0.1 μg/ml) provided the
second highest yield of metaphases (8%).
4. With the aim of optimizing the quality of metaphase
spreading, we tested two different hypotonic treat-
ments. We set as first parameter for our quality analysis
the average number of chromosome overlaps per
metaphase. A high number of overlaps makes chromo-
some identification laborious and can ultimately hinder
high-quality karyotypic analysis. The average number
of chromosome overlaps was measured and compared
in HUES-2 cells treated with either demecolcine or
nocodazole, both at 0.1 μg/ml for 16 h, and harvested
with either a standard hypotonic solution (0.075 M
KCl) or a buffered hypotonic solution (0.4% KCl with
Table 3 Metaphase spread quality assessment: chromosome overlaps








Nocodazole/standard hypotonic 12.8 5–23 5.988 p<0.001
Nocodazole/buffered hypotonic 4.8 0–16 4.5
Demecolcine/standard hypotonic 12.6 4–23 6.3369 p<0.001
Demecolcine/buffered hypotonic 4.3 0–10 3.9636
Fig. 3 Chromosome length as a parameter for metaphase spread
quality for karyotype analysis. The average length of chromosome 1
(here with the centromeric region marked in red) was measured using
the image analysis package MetaMorph v7.6 (example above), and
compared between the nocodazole 16 h/buffered hypotonic harvest
and the demecolcine 16 h/buffered hypotonic harvest
Stem Cell Rev and Rep (2011) 7:471–477 475HEPES), obtained commercially. We randomly
acquired and analyzed twenty-five metaphases from
each of the four different harvesting conditions (Fig. 2).
We initially scored the number of overlaps between
chromosomes per metaphase (Table 3). In some cases,
where the metaphase quality was poor and it was
impossible to distinguish individual chromosomes, we
assigned an arbitrary maximum overlap number of 23,
meaning that all the chromosomes were involved in at
least one overlapping event. When the different
harvests were compared, the number of overlaps in
chromosomes harvested with the buffered hypotonic
solution—following either nocodazole or demecolcine
treatment—was significantly lower than in chromo-
somes harvested with the standard hypotonic solution
(p<0.001, Student’s T-test for independent samples). In
contrast, neither the difference between nocodazole and
demecolcine harvests after buffered hypotonic (p=
0.335) nor the difference between nocodazole and
demecolcine harvests after standard hypotonic (p=
0.47) was significant. The pH of the cell preparations
resuspended in the standard hypotonic solution was
slightly acidic (pH 6.5–6.7), similar to the pH of the
spent tissue culture medium, while the buffered
hypotonic solution maintained a pH of 7.4. The
chromosome suspensions obtained by “acidified” KCl
were consistently of poor quality, in comparison to the
preparation obtained with the buffered hypotonic
treatment. However, the addition of a PBS wash, before
resuspending the cells in hypotonic, lead to a slight
improvement in the KCl-prepared metaphase quality,
but decreased their overall number.
Fig. 4 Twenty-four color kar-
yotyping of hES cells (HUES-2
and HUES-10) and iPS-DF19-9-
11T.H by M-FISH. The high
standard and improved speed of
the M-FISH analysis have
together confirmed the newly
identified optimal mitotic arrest
and hypotonic conditions to
provide a significant technical
breakthrough for chromosomal
analysis of hES and hiPS cells.
While HUES-10 (passage 37)
and iPS-DF19-9-11T.H (passage
29) presented a normal karyo-
type, M-FISH analysis on
HUES-2 at passage 40 revealed,
as well as chromosome 12
partial trisomy, a couple of
structural abnormalities to
include a translocation involving
an extra copy of chromosome 1q
and chromosome 18, and an
unbalanced translocation in-
volving chromosomes 17 and 22
476 Stem Cell Rev and Rep (2011) 7:471–4775. The average chromosome length was set as the second
parameter for metaphase spread quality. Increased chro-
mosome length means improved chromosomal morphol-
ogy and, most importantly, improved longitudinal
resolution for karyotyping purposes. For our analysis we
chose chromosome 1—the longest chromosome—to
reduce the% error during measurements. The length of
the two chromosome 1 homologues was measured in μm
using the image analysis package MetaMorph v7.6
(Molecular Devices Inc, Danaher Corporation, U.S.A.)
in twenty-five randomly captured metaphases from
chromosome harvests prepared using the buffered hypo-
tonic, which had given the best results in the previous
assay (Fig. 3). The average length of chromosome 1 in
the demecolcine 16 h/buffered hypotonic harvest was
found to be 20% lower than the average length of
chromosome 1 in the nocodazole 16 h/buffered hypo-
tonic solution harvest (Student t-test for independent
samples showing a two tailed p value of 0.01).
6. Having established—on the basis of the number and
quality of metaphase spreads recovered- the ‘0.1 μg/ml
nocodazole 16 h/buffered hypotonic solution’ to be the
best protocol combination for chromosome harvests of
hES cells, we proceeded to further confirm its suitability
for FISH-based karyotyping techniques by analyzing by
M-FISH chromosome spreads obtained from the three
different cell lines used in this study, namely HUES-2
(passage 40), HUES-10 (passage 37) and iPS-DF19-9-
11T.H (passage 29) (Fig. 4). M-FISH was performed as
recommended by the 24XCyte mFISH probe kit manu-
facturer. The high standard and improved speed of the M-
FISH analysis together confirmed the newly identified
mitotic arrest and hypotonic conditions as optimal.
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